ultrasonography showed a nonspecific mass located around the upper pole of the right kidney and abdominal computed tomography revealed a right adrenal neoplasm measuring 45 × 29 mm in diameter and bulging out toward the liver (Figures 1 and 2) .
Physical examination revealed a tender palpable right upper quadrant mass. Laboratory studies were significant for anemia (6.2 g/dl) and leukocytosis (1.19 × 10 3 /µl). Hormone panel including serum and urinary metanephrines, serum and urinary cortisol, plasma aldosterone, and serum adrenocorticotropic hormone was normal. Ten days after hospitalization, follow up chest-abdomen and pelvis CT scan re- vealed enlargement of the adrenal mass from 45 × 29 mm to 65 × 45 mm. New bilateral lung nodules were also noted (Figures 3 and 4) .
Therefore, fine-needle aspiration (FNA) was performed. Histological sections showed sheets of epithelioid cells in a fibrotic stroma and focal necrosis. Cells have eosinophilic cytoplasm, prominent nucleoli and frequent mitotic figures. These histologic features were consistent with malignant neoplasm. Further studies with pax8, cytokeratin 19, claudin, calretinin, synaptophysin, chromogranin A, glypican-3, human melanoma black 45 and MART-1, and cytokeratin (AE1/AE3) were performed. The tumor cells were positive for cytokeratin and negative for all the remaining markers. A second panel of immunostains including CD31, cytokeratin, and ERG-1 was performed. Tumor cells were strongly positive for all ( Figure 5 ). Hence, the diagnosis of epithelioid angiosarcoma was made. Unfortunately, the patient died few days after the histological diagnosis. dIsCussIon Angiosarcomas are very rare malignant tumors, which derive from the vascular endothelium and can occur at any site in the body [2] . Epithelioid angiosarcoma (EA) of the adrenal gland has poor prognosis: 5-year overall survival ranges between 25% and 45% in primary tumors, while is shorter than 12 months in metastatic patients [3] . To our knowledge, just 37 Fine-needle aspiration accuracy in the diagnosis of primary epithelioid angiosarcoma of the adrenal gland been reported in literature. Nevertheless, among them, only 29 are available for full review in English, according to PubMed systemic research through MeSH terms (Table I) .
The etiology of EA remains unknown: apart from a case of exposure to arsenic [6] and a case of exposure to vynil chloride [29] , the published case reports didn't succeed in identifying a clear correlation with the patients' exposure to carcinogens or with a significant incidence of other diseases, even though three patients had concomitant adrenal cortical adenoma [26, 31, 32] (Table I ). The disease occurs more frequently in males (M/F= 28/9), ranges from 34 to 85 years of age, with a mean peak at 57 years.
Patients can either be asymptomatic or suffer from weight loss, slight fever, anorexia, fatigue, weakness, and chronic pain in the upper abdominal quadrants, as in our patient. No increase in adrenal gland hormones production is noted in most of the reported cases, even though two patients had Cushing's syndrome [9, 15] and in three patients the disease was discovered for the sudden onset of hypertension, despite none of them had increased plasmatic aldosterone or metanephrines [26, 31, 33] .
Actually, CT scan is the most used radiological tool for diagnostic purpose, even if F 18 FDG PET/CT may be useful too [27] . Although adrenal angiosarcoma does not have a distinct gross pattern, a review of the literature showed that it tends to have a round, solid, and heterogeneous aspect. Frequently, it is a cystic mass and can range in size from 3 cm to 16 cm (Table I) . Clinicians and pathologists should include primary adrenal angiosarcoma in the differential diagnoses list for large adrenal gland mass [34] .
One can speculate that the rich adrenal vasculature may create a favorable milieu for hemorrhagic and necrotic changes, while the high mitotic index may explain both the solid pattern and the huge volume of the tumor that is often found.
In this case, the differential diagnosis includes metastatic malignancy and other primary adrenal tumors. Epithelioid angiosarcomas can imitate carcinomas morphologically and immune-phenotypically. Metastatic or primary melanoma can also show both epithelioid and spindled morphology. Among benign and malignant neoplasms that may simulate epithelioid angiosarcoma, there are adrenal adenoma undergoing massive hemorrhage and epithelioid hemangioendothelioma. Moreover, the diagnosis of angiosarcoma can be a challenge due to pathohistologic features mimicking intravascular papillary endothelial hyperplasia (IPEH -Masson's tumor). IPEH is a benign, reactive process that cannot be radiologically differentiated from other benign or malignant lesions [35] .
Because of its rarity, in literature there is only one previous case of adrenal angiosarcoma diagnosed by fine-needle aspiration (FNA) [25] . In fact, owing to its epithelioid morphology, this tumor may be mistaken for other neoplasms. Sometimes, the difficult diagnosis may cause an insufficient surgical approach. If the tumor is confined to the adrenal gland, it is suggested to remove it, and also take the periadrenal fat tissue and pericaval or periaortic tissue out in order to eradicate any site of potential local tumor microinfiltration. Involved organs, such as liver, spleen, pancreas, kidney, or bowel must be removed [16] . Too often, patients undergo surgery before a proper diagnosis is made and the high incidence of local relapses may sometimes be explained by inadequate approaches. Laparoscopy may be used carefully in district surgeries: among the studied case reports, it was used in four patients with a follow up no longer than one year [13, 26, 29, 31] .
So far, diagnostic process is supported by histopathology and immunohistochemistry. Epithelioid angiosarcomas are morphological variants of angiosarcomas, in which polygonal endothelial cells with "epithelioid" appearance predominate and are often arranged in solid nests and sheets, mimicking carcinoma. Although irregular, anastomosing vascular channels are commonly identified within the lesion, supporting the diagnosis. Malignant cells stain positively for endothelial markers CD31, factor VIII, and Fli-1. CD34 is reported to be less sensitive even though it is present in about 40% of cases (Table II) . Most epithelioid angiosarcomas co-express cytokeratin and diagnostic errors may be promoted by immunohistochemical reactivity for this marker. In fact, cytokeratin reactivity may also occur in non-epithelial tumors like mesenchymal ones and the literature shows a lot of studies documenting the presence of cytokeratin in these tumors. Therefore, cytokeratin immunoreactivity may be considered as "aberrant expression" or "cross-reactivity" of this marker [36] .
Surgery, combined with chemotherapy, represents the mainstay of treatment. Chemotherapy is preferably used in neoadjuvant setting to shrink the tumor and eventually
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ConClusIons
Epithelioid adrenal angiosarcoma is a very rare tumor and only 37 cases are reported in scientific literature. It is very aggressive and has poor long term prognosis. Such data show that early diagnosis is mandatory. Nevertheless, early diagnosis is rarely made since the tumor may be asymptomatic or present with aspecific symptoms, like slight fever, anorexia, fatigue or general pain or discomfort in the upper parts of the abdomen. Actually, endocrine tests are not indicative and the radiology workup may suggest just an indistinct malignancy.
Even if histomorphological and immunohistochemical studies are time-consuming, they are an essential part of the definitive diagnosis and FNA may be an helpful tool to obtain a preoperative and definitive diagnosis.
Unfortunately, sometimes diagnosis is made when disease is advanced, with no therapeutic options, as happened in this case. In advanced or metastatic disease, cytotoxic chemotherapy based on the same active drugs is the treatment of choice. Even if the response rate of angiosarcoma to these treatments is higher than other tumors, in most cases their dose-limiting toxic effects (mostly cardiac and neurological) do not allow to use these therapies longer than 6 months [3] . Thus, new and non-toxic drugs are strongly needed. Among new anti-angiogenetic therapies, activity of sorafenib, sunitinib, bevacizumab, and thalidomide has been recently described, obtaining response rates up to 15% [37, 38] . Especially in palliative setting, where the goal is to increase survival and preserve the quality of life, the sequential use of taxanes and gemcitabine could be, probably in most cases, more advisable than their combination [39] .
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